Literature DB >> 19589914

Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis.

Cheryl L Robbins1, Maura K Whiteman, Susan D Hillis, Kathryn M Curtis, Jill A McDonald, Phyllis A Wingo, Aniket Kulkarni, Polly A Marchbanks.   

Abstract

INTRODUCTION: Although many studies have examined the influence of reproductive factors on ovarian cancer risk, few have investigated their effect on ovarian cancer survival. We examined the prognostic influence of reproductive factors on survival after ovarian cancer diagnosis.
METHODS: We conducted a longitudinal analysis of 410 women, ages 20 to 54 years, who participated in the 1980 to 1982 Cancer and Steroid Hormone study as incident ovarian cancer cases. We obtained their vital status by linking Cancer and Steroid Hormone records with Surveillance, Epidemiology, and End Results data. We used the Kaplan-Meier approach to estimate survival probabilities and Cox proportional hazards models to estimate hazard ratios (HR) and 95% confidence intervals (95% CI).
RESULTS: During a median follow-up of 9.2 years, 212 women died. Of the reproductive factors examined, only age at menarche and number of lifetime ovulatory cycles (LOC) relative to age significantly predicted ovarian cancer survival. Risk for death was higher among women with highest number of LOC compared with those having fewest LOC (HR, 1.67; 95% CI, 1.20-2.33). Women with fewest LOC had the highest 15-year survival (56.7%; 95% CI, 47.8-64.6%), and women with the highest LOC had the poorest (33.3%; 95% CI, 25.3-41.5%). Women whose age at menarche was <12 years had a higher risk of death compared with women whose menses began at > or =14 years (HR, 1.51; 95% CI, 1.02-2.24).
CONCLUSIONS: We found that high LOC and early age at menarche were associated with decreased survival after ovarian cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19589914     DOI: 10.1158/1055-9965.EPI-09-0156

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  6 in total

1.  Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.

Authors:  Seijeoung Kim; Therese A Dolecek; Faith G Davis
Journal:  Soc Sci Med       Date:  2010-04-22       Impact factor: 4.634

2.  Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Authors:  Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen
Journal:  Am J Epidemiol       Date:  2016-04-15       Impact factor: 4.897

3.  Reproductive Factors Do Not Influence Survival with Ovarian Cancer.

Authors:  Minh Tung Phung; Aliya Alimujiang; Andrew Berchuck; Hoda Anton-Culver; Joellen M Schildkraut; Elisa V Bandera; Jenny Chang-Claude; Anne Chase; Jennifer Anne Doherty; Bronwyn Grout; Marc T Goodman; Gillian E Hanley; Alice W Lee; Cindy McKinnon Deurloo; Usha Menon; Francesmary Modugno; Paul D P Pharoah; Malcolm C Pike; Jean Richardson; Harvey A Risch; Weiva Sieh; Kathryn L Terry; Penelope M Webb; Nicolas Wentzensen; Anna H Wu; Celeste Leigh Pearce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

4.  Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases.

Authors:  Amy L Shafrir; Ana Babic; Rulla M Tamimi; Bernard A Rosner; Shelley S Tworoger; Kathryn L Terry
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

5.  Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.

Authors:  Shana J Kim; Barry Rosen; Isabel Fan; Anna Ivanova; John R McLaughlin; Harvey Risch; Steven A Narod; Joanne Kotsopoulos
Journal:  Br J Cancer       Date:  2017-02-16       Impact factor: 7.640

6.  Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.

Authors:  Jelena Bešević; Marc J Gunter; Renée T Fortner; Konstantinos K Tsilidis; Elisabete Weiderpass; N Charlotte Onland-Moret; Laure Dossus; Anne Tjønneland; Louise Hansen; Kim Overvad; Sylvie Mesrine; Laura Baglietto; Françoise Clavel-Chapelon; Rudolf Kaaks; Krasimira Aleksandrova; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Giovanna Masala; Claudia Agnoli; Rosario Tumino; Fulvio Ricceri; Salvatore Panico; H Bas Bueno-de-Mesquita; Petra H Peeters; Mie Jareid; J Ramón Quirós; Eric J Duell; María-José Sánchez; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte; Joana A Dias; Emily Sonestedt; Annika Idahl; Eva Lundin; Nicholas J Wareham; Kay-Tee Khaw; Ruth C Travis; Sabina Rinaldi; Isabelle Romieu; Elio Riboli; Melissa A Merritt
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.